ClearArc Capital’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
MWNA
ClearArc Capital's DGX Position: Q4 2019 in Review
ClearArc Capital sold out of Quest Diagnostics (DGX) in Q4 2019, closing a stake of 2,029 shares — an estimated $217K sold.
ClearArc Capital first reported a position in DGX in Q4 2014 and held it in 19 quarters. The position peaked at $1.11M in Q1 2015. 712 funds tracked by Wall St. Rank hold DGX as of Q4 2019.
- ClearArc Capital reported no remaining Quest Diagnostics position as of Q4 2019 after selling out during the quarter.
- ClearArc Capital sold 2,029 Quest Diagnostics shares in Q4 2019, an estimated $217K.
- ClearArc Capital first reported a position in Quest Diagnostics in Q4 2014 and held it in 19 quarters.
- ClearArc Capital's Quest Diagnostics position peaked at $1.11M in Q1 2015.
- 712 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2019.
Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.